AFT to pay first dividend as income soars 20%

maxigesic pack shot
Kiwi Maxigesic owner posts $NZD20m profit boosted by licensing income  AFT Pharmaceuticals, the New Zealand-headquartered outfit best known for its Maxigesic ibuprofen/paracetamol combination, will pay its first dividend in its eight year history as a publicly listed company on the back of boosted revenue. The dual NZX/ASX-listed company’s full year FY2023 result showed its operating

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous The week in review
Next GSK's $1.5b payday